Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Arimont

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Pharmacology|July 4, 2019
Chemokine Receptor Crystal Structures: What Can Be Learned from Them?Marta Arimont, Carsten Hoffmann, Chris de Graaf, et al.
International Journal of Molecular Sciences|April 30, 2021
Analysis of Missense Variants in the Human Histamine Receptor Family Reveals Increased Constitutive Activity of E410<sup>6.30×30</sup>K Variant in the Histamine H<sub>1</sub> ReceptorXiaoyuan Ma, Marta Arimont Segura, Barbara Zarzycka, et al.
Journal of Medicinal Chemistry|February 7, 2017
Structural Analysis of Chemokine Receptor-Ligand InteractionsMarta Arimont, Shan-Liang Sun, Rob Leurs, et al.
Molecular Pharmacology|September 5, 2019
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3Vladimir Bobkov, Marta Arimont, Aurélien Zarca, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2020
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonistsAli Işbilir, Jan Möller, Marta Arimont, et al.
Molecular Pharmacology|September 25, 2019
Modulators of CXCR4 and CXCR7/ACKR3 FunctionIlze Adlere, Birgit Caspar, Marta Arimont, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2024
Conformational dynamics underlying atypical chemokine receptor 3 activationOmolade Otun, Christelle Aljamous, Elise Del Nero, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)Sebastian Dekkers, Dehan Comez, Noemi Karsai, et al.
Iscience|September 5, 2022
Optical control of the β<sub>2</sub>-adrenergic receptor with opto-prop-2: A <i>cis</i>-active azobenzene analog of propranololReggie Bosma, Nicola C Dijon, Yang Zheng, et al.
Biochemical Pharmacology|October 21, 2018
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functionsVladimir Bobkov, Aurelien M Zarca, Anneleen Van Hout, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Pharmacology|July 4, 2019
Chemokine Receptor Crystal Structures: What Can Be Learned from Them?Marta Arimont, Carsten Hoffmann, Chris de Graaf, et al.
International Journal of Molecular Sciences|April 30, 2021
Analysis of Missense Variants in the Human Histamine Receptor Family Reveals Increased Constitutive Activity of E410<sup>6.30×30</sup>K Variant in the Histamine H<sub>1</sub> ReceptorXiaoyuan Ma, Marta Arimont Segura, Barbara Zarzycka, et al.
Journal of Medicinal Chemistry|February 7, 2017
Structural Analysis of Chemokine Receptor-Ligand InteractionsMarta Arimont, Shan-Liang Sun, Rob Leurs, et al.
Molecular Pharmacology|September 5, 2019
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3Vladimir Bobkov, Marta Arimont, Aurélien Zarca, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2020
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonistsAli Işbilir, Jan Möller, Marta Arimont, et al.
Molecular Pharmacology|September 25, 2019
Modulators of CXCR4 and CXCR7/ACKR3 FunctionIlze Adlere, Birgit Caspar, Marta Arimont, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2024
Conformational dynamics underlying atypical chemokine receptor 3 activationOmolade Otun, Christelle Aljamous, Elise Del Nero, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)Sebastian Dekkers, Dehan Comez, Noemi Karsai, et al.
Iscience|September 5, 2022
Optical control of the β<sub>2</sub>-adrenergic receptor with opto-prop-2: A <i>cis</i>-active azobenzene analog of propranololReggie Bosma, Nicola C Dijon, Yang Zheng, et al.
Biochemical Pharmacology|October 21, 2018
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functionsVladimir Bobkov, Aurelien M Zarca, Anneleen Van Hout, et al.
Pageof 2